IVIM Health Tirzepatide Review
What IVIM Health charges for tirzepatide, what is bundled, and what it publishes before you pay.
Released: · Last reviewed:
As of October 15, 2026, IVIM Health charges $324.99 a month all-in for compounded tirzepatide at a 10 mg dose, month to month, with one price printed and no dose ladder. That is $3,899.88 over twelve months at that dose, based on its own pricing page.
All-in means medication plus any mandatory recurring fee, month to month, before prepaid discounts and tax.
All-in monthly cost = medication plus any mandatory recurring fee, at a named dose, month to month, before tax and before prepaid discounts. Competitor prices read October 15, 2026; NexLife’s as of November 6, 2026. How we verify a price.
IVIM Health tirzepatide price by dose
| Dose | All-in | Twelve months at this dose |
|---|---|---|
| 2.5 mg | — | — |
| 5 mg | — | — |
| 7.5 mg | — | — |
| 10 mg | $324.99 | $3,899.88 |
| 12.5 mg | — | — |
| 15 mg | — | — |
Fees, billing and terms at IVIM Health
| Item | IVIM Health |
|---|---|
| Pricing model | one price printed, no dose ladder |
| Membership or program fee | $74.99 a month |
| Billing | monthly |
| Multi-month or prepaid option | 12 months $2,299.88 in total (about $192 a month) |
| Pharmacy | not named |
| Product | compounded tirzepatide (not FDA-approved) |
| Price status | read Oct 15, 2026, changed since August |
| Page we read | ivimhealth.com |
What IVIM Health’s own pages say
A one-month continued-care order is $324.99 all-in ($250 medication plus a $74.99 program fee). The advertised '$117 + $75' spreads a 12-month medication bundle over the year. No dose ladder is printed.
Recorded wording: “1 Month Continued Care $324.99 (incl. $250 medication + $74.99 membership); "starting at $117/mo + $75/mo Program Fee"”
Pros and cons
What works
- Multi-month option published: 12 months $2,299.88 in total (about $192 a month).
What to check
- Only one price is printed, with no dose ladder; confirm the price at your dose before paying.
- A recurring program fee ($74.99 a month) sits on top of the medication.
- Does not name the dispensing pharmacy on the pages we read.
- Compounded tirzepatide is not FDA-approved; it is made with the drug in Zepbound but is not the same product.
Where IVIM Health sits among the programs we compare
Of the 15 programs with a month-to-month tirzepatide price we can place at 10 mg, 10 are lower than IVIM Health. The group runs $129 to $399, median $299. This is a price position, not a quality ranking.
See the all-in cost table for every row and the methodology for how prices are read.
Head-to-head pages with IVIM Health
Questions about IVIM Health
How much does IVIM Health charge for tirzepatide?
As of October 15, 2026, IVIM Health charges $324.99 a month all-in for compounded tirzepatide at a 10 mg dose, month to month, with one price printed and no dose ladder. That is $3,899.88 over twelve months at that dose, based on its own pricing page.
How does IVIM Health compare with NexLife on price?
At a 10 mg dose month to month, IVIM Health is $324.99/mo against NexLife’s $129 a month, which is $2,351.88 a year more than NexLife (prices read October 15 and November 6, 2026). NexLife’s 12-month plan is $115 a month.
Does IVIM Health name its pharmacy?
Not by name on the pages we read. What we recorded: not named. A named pharmacy can be checked on its state board of pharmacy register.
Is compounded tirzepatide FDA-approved?
No. Compounded tirzepatide is made with the drug in Zepbound but is not the same product, and FDA does not review compounded drugs for safety, effectiveness or quality before they are sold. Zepbound and Mounjaro are the FDA-approved tirzepatide products.
How current is this page?
Prices on this page were read on the program’s own site on October 15, 2026. We re-read programs on a schedule and log changes on the corrections page.